BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE
169 results:

  • 1. DMC-siERCC2 hybrid nanoparticle enhances TRAIL sensitivity by inducing cell cycle arrest for glioblastoma treatment.
    Song M; Wang T; Liu T; Lei T; Teng X; Peng Q; Zhu Q; Chen F; Zhao G; Li K; Qi L
    Biomed Pharmacother; 2024 May; 174():116470. PubMed ID: 38565061
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Presentation and outcomes of paediatric craniopharyngioma in the west of Scotland: a 25 year experience.
    Kuah XYC; Lucas-Herald AK; McCarrison S; Boyle R; Adey C; Amato-Watkins A; Bhattathiri P; Campbell E; Cowie F; Dorris L; Fulton B; Mcintosh D; Murphy D; Ronghe M; O'Kane R; Todd L; Sangra M; Sastry J; Millar E; Hassan S; Shaikh MG
    J Neurooncol; 2024 Jan; 166(1):51-57. PubMed ID: 38224403
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A novel BRAF::PTPRN2 fusion in meningioma: a case report.
    Sadagopan NS; Nandoliya KR; Youngblood MW; Horbinski CM; Ahrendsen JT; Magill ST
    Acta Neuropathol Commun; 2023 Dec; 11(1):194. PubMed ID: 38066633
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. LncRNA INHEG promotes glioma stem cell maintenance and tumorigenicity through regulating rRNA 2'-O-methylation.
    Liu L; Liu Z; Liu Q; Wu W; Lin P; Liu X; Zhang Y; Wang D; Prager BC; Gimple RC; Yu J; Zhao W; Wu Q; Zhang W; Wu E; Chen X; Luo J; Rich JN; Xie Q; Jiang T; Chen R
    Nat Commun; 2023 Nov; 14(1):7526. PubMed ID: 37980347
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumors.
    Chen W; Guo S; Wang Y; Shi Y; Guo X; Liu D; Li Y; Wang Y; Xing H; Xia Y; Li J; Wu J; Liang T; Wang H; Liu Q; Jin S; Qu T; Li H; Yang T; Zhang K; Wang Y; Ma W
    Cancer Med; 2023 Sep; 12(18):18666-18678. PubMed ID: 37667984
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.
    Williams EA; Brastianos PK; Wakimoto H; Zolal A; Filbin MG; Cahill DP; Santagata S; Juratli TA
    Acta Neuropathol; 2023 Sep; 146(3):515-525. PubMed ID: 37524847
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A Potential Anti-Glioblastoma Compound LH20 Induces Apoptosis and Arrest of Human Glioblastoma Cells via CDK4/6 Inhibition.
    Wang Y; Li Y; Liu D; Zheng D; Li X; Li C; Huang C; Wang Y; Wang X; Li Q; Xu J
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446710
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical features and therapeutic outcomes of GH/TSH cosecreting pituitary adenomas: experience of a single pituitary center.
    Yu N; Duan L; Hu F; Yang S; Liu J; Chen M; Yao Y; Deng K; Feng F; Lian X; Mao X; Zhu H
    Front Endocrinol (Lausanne); 2023; 14():1197244. PubMed ID: 37324275
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. miR-3174 Is a New Tumor Suppressor MicroRNA That Inhibits Several Tumor-Promoting Genes in Glioblastoma.
    Hanif F; Zhang Y; Dube C; Gibert MK; Saha S; Hudson K; Marcinkiewicz P; Kefas B; Guessous F; Abounader R
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298284
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Lipophagy-related gene RAB7A is involved in immune regulation and malignant progression in hepatocellular carcinoma.
    Liu Y; Ma J; Wang X; Liu P; Cai C; Han Y; Zeng S; Feng Z; Shen H
    Comput Biol Med; 2023 May; 158():106862. PubMed ID: 37044053
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A review on the role of SNHG8 in human disorders.
    Ghafouri-Fard S; Harsij A; Hussen BM; Taheri M; Ayatollahi SA
    Pathol Res Pract; 2023 May; 245():154458. PubMed ID: 37043963
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Exosomal RNAs in the development and treatment of pituitary adenomas.
    Chang M; Jiang S; Guo X; Gao J; Liu P; Bao X; Feng M; Wang R
    Front Endocrinol (Lausanne); 2023; 14():1142494. PubMed ID: 36875488
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Increased BMI and late-life mobility dysfunction; overlap of genetic effects in brain regions.
    Chang X; Chua KY; Ng FL; Wang L; Liu J; Yuan JM; Khor CC; Heng CK; Dorajoo R; Koh WP
    Int J Obes (Lond); 2023 May; 47(5):358-364. PubMed ID: 36788305
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.
    Chai RC; Yan H; An SY; Pang B; Chen HY; Mu QH; Zhang KN; Zhang YW; Liu YQ; Liu X; Zhao Z; Jiang T; Wang YZ; Jia WQ
    Brain Pathol; 2023 Jul; 33(4):e13153. PubMed ID: 36751054
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MYB/MYBL1::QKI fusion-positive diffuse glioma.
    Suh YY; Lee K; Shim YM; Phi JH; Park CK; Kim SK; Choi SH; Yun H; Park SH
    J Neuropathol Exp Neurol; 2023 Feb; 82(3):250-260. PubMed ID: 36592415
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered.
    Zhao JP; Liu XJ; Lin HZ; Cui CX; Yue YJ; Gao S; Xu HZ
    BMC Neurol; 2022 Dec; 22(1):498. PubMed ID: 36550486
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma.
    Parmar A; Ghosh S; Sahgal A; Lalani AA; Hansen AR; Reaume MN; Wood L; Basappa NS; Heng DYC; Graham J; Kollmannsberger C; Soulières D; Breau RH; Tanguay S; Kapoor A; Pouliot F; Bjarnason GA
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1763. PubMed ID: 36517084
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. FAM84B promotes the proliferation of glioma cells through the cell cycle pathways.
    Ren D; Zhuang X; Lv Y; Zhang Y; Xu J; Gao F; Chen D; Wang Y
    World J Surg Oncol; 2022 Nov; 20(1):368. PubMed ID: 36419094
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors.
    Zhang F; Zhang Q; Zhu J; Yao B; Ma C; Qiao N; He S; Ye Z; Wang Y; Han R; Feng J; Wang Y; Qin Z; Ma Z; Li K; Zhang Y; Tian S; Chen Z; Tan S; Wu Y; Ran P; Wang Y; Ding C; Zhao Y
    Cell Res; 2022 Dec; 32(12):1047-1067. PubMed ID: 36307579
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. IKBIP, a novel glioblastoma biomarker, maintains abnormal proliferation of tumor cells by inhibiting the ubiquitination and degradation of CDK4.
    Li K; Huang G; Wang Z; Yang R; Zhang W; Ni B; Guan J; Yi G; Li Z; Zhu Q; Peng Q; Yang L; Qi L; Liu Y
    Biochim Biophys Acta Mol Basis Dis; 2023 Jan; 1869(1):166571. PubMed ID: 36244542
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.